About this trial
The primary aim of the study is to derive and validate risk scores for vascular endpoints (recurrent stroke, myocardial infarction, and other complications of stroke) and for death following an incident stroke. For this purpose patients with an incident stroke will be followed for 36 months with additional assessments at 3, 12, 24 and 36 months.
Eligibility criteria
Qualifiers
Age ≥18 years
Language: German
First ever acute ischemic stroke that occurred with stroke onset in the last 7 days
Written informed consent by patient prior to study participation
Disqualifiers
Prior stroke (definition according to WHO criteria)
Patients presenting brain tumour or brain metastasis
Participation in an intervention- / AMG-study
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Ludwig-Maximilians - University of Munich
Lead sponsor
Charite University, Berlin, Germany
Collaborator